Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis-Reference-Cited by-同舟云学术

Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis

Published:2010-04-30 Issue:4 Volume:23 Page:542-553
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:

Author:

Ryan Denise,Rafferty Mairin,Hegarty Shauna,O’Leary Patrick,Faller William,Gremel Gabriela,Bergqvist Michael,Agnarsdottir Margret,Strömberg Sara,Kampf Caroline,Pontén Fredrik,Millikan Robert C.,Dervan Peter A.,Gallagher William M.

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-148X.2010.00720.x/fullpdf

Reference65 articles.

1. Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma;Barks;Genes Chromosomes Cancer,1997

2. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization;Bastian;Cancer Res.,1998

3. Classifying melanocytic tumors based on DNA copy number changes;Bastian;Am. J. Pathol.,2003

4. An activity from mammalian cells that untwists superhelical DNA - a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay);Champoux;Proc. Natl. Acad. Sci. USA,1972

5. Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy;Chen;Gynecol. Oncol.,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Vesicles in the Skin Microenvironment: Emerging Roles as Biomarkers and Therapeutic Tools in Dermatologic Health and Disease;Journal of Investigative Dermatology;2024-02

2. Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma;Oncoscience;2023-09-20

3. Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis;Frontiers in Cell and Developmental Biology;2023-01-10

4. High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma;Translational Oncology;2022-01

5. TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors;Pharmacological Research;2021-11